Further analysis of the number of circulating GFP-tagged tumor cells in the bloodstream at the time of sacrifice indicated tumor cells in the circulation were reduced by ∼50% in tumor-bearing HIF-1α endothelial cell deletion mutants (Figure 1C, right). The gene discussed is HIF1A; the disease is neoplasm.